March 19, 2020

Contract Pharma Reports, Bright Path Labs Accepted into FDA’s Emerging Technology Program

MONTVALE, NJ — Bright Path Laboratories, Inc. (BPL), a provider of continuous flow reactor technology, was accepted into the FDA’s Emerging Technology Program, paving the way […]
February 19, 2018

Medicine-for-All Institute (VCU) selects BPP as First Commercial Manufacturing Partner

RICHMOND, VA  — Bright Path Pharmaceuticals, LLC (privately held) today announced that the Medicines for All Institute, a joint venture between Virginia Commonwealth University and the […]
December 8, 2017

ChemWerth’s Dr. Xiping Su joins BPP’s Board

RICHMOND, VA  —  Bright Path Pharmaceuticals, LLC (privately held), today announced that ChemWerth’s Chief Scientific Officer, Dr. Xiping Su, has joined the Board of the company following […]
August 28, 2017

Todd N. Smith joins BPP Board

CHARLOTTE, NC — Bright Path Pharmaceuticals, LLC (privately held) today announced that Todd N. Smith, Chairman and CEO of Novum Pharma will join the Board.  Mr. […]